Skip to content

Internet-Based Depression Screening for College Students

Internet-Based Depression Screening for College Students

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01326793
Enrollment
1900
Registered
2011-03-31
Start date
2008-09-30
Completion date
2014-12-31
Last updated
2015-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Keywords

telepsychiatry, MDD, Depression, Major Depressive Disorder, Skype, college, university

Brief summary

This study aims to determine whether using telecommunication tools, specifically web pages containing online screening instruments and real-time video chat, will be an efficient way to implement Major Depressive Disorder screening among college students. The study also aims to determine if proactive depression screening and free online consultation with a psychiatrist will increase the rate of help-seeking among college students with MDD. Eligible participants will complete a demographics survey and depression screening assessment online. Those subjects who express suicidality or depressive symptoms will be offered the opportunity to complete a one-time psychiatric consultation with Skype video-conferencing.

Interventions

OTHERSkype Consultation

One-hour Skype consultation with MA-licensed psychiatrist and a written summary of findings.

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* All who consider themselves current undergraduate from Massachusetts colleges are encouraged to participate.

Design outcomes

Primary

MeasureTime frameDescription
9-item Patient Health QuestionnaireBaseline, Week 8Subjects are given the PHQ-9 at baseline, and a 8-week follow-up survey that includes PHQ-9 and questions inquiring whether subject has begun treatment for MDD and whether they faced obstacles in seeking treatment.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026